Clinical Trial Update: Faricimab Quarterly Maintenance for Neovascular Age Related Macular Degeneration [Phase 4]

View source ↗

Summary

This document reports an ongoing Phase 4 trial of faricimab for neovascular age-related macular degeneration, focusing on quarterly maintenance dosing and curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Faricimab (faricimab)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Macular Degeneration Choroidal Neovascularization | Phase 4 | Status: RECRUITING